Friday, 5 September 2014
The latest developments of the Pharmaceutical Sector in Romania
The 1,600 Romanian companies that have as main object of activity drug distribution reached a cumulative turnover of 5.3 billion EUR in 2013, an increase of 60% compared to the level reached in 2008, the best year for the Romanian economy. Their cumulative profit was of 178 mil EUR compared with 97 mil EUR in 2008.
According to our research, the main three distributors of drugs in Romania are: Mediplus Exim, Farmexpert and Farmexim. In 2013, they have recorded a cumulated net profit of almost 29 million EUR.
Three of the main pharmacies networks in Romania are: Sensiblu, S.I.E.P.C.O.F.A.R. (Dona Pharmacies) and Help Net Farma. According to the FRD Center research, they have recorded a cumulated net turnover of 516 million EUR in 2013, up by 5% compared to 2012.
Some main local representatives of international drug manufactures are: Sanofi Aventis, Pfizer and Krka. In 2013, they have recorded a cumulated net profit of over ten million EUR.
Terapia Ranbaxy, the local subsidiary of Ranbaxy Laboratories, has registered in 2013 a net profit of almost 25 million EUR, up by some 14% compared to the previous year. Ranbaxy Laboratories has entered the Romanian market by acquiring the local drugs manufacturer Terapia in 2006.
The Hungarian pharmaceutical group Gedeon Richter has reported sales of 74.9 million EUR in Romania in the first six months of 2014, up by 5.2% compared to the same period of the previous year.
Zentiva, controlled by the French Group Sanofi, has recorded in 2013 a net profit of aproximately 9 million EUR, up by some 26% compared to the previous year.
For tailored market data on Romania and other markets in Eastern Europe, do not hesitate to contact out team at firstname.lastname@example.org or +4021 4111459
Our website: www.frdcenter.ro